Pharmacogenomic markers
drug-wise marker evidence and screened non-findings ▾
Marker-level frequencies do not establish star alleles, diplotypes, copy number, HLA type or metabolizer phenotype. A zero effect-allele frequency is retained as a screened population-level non-finding.
GWAS and association-study SNPs
trait associations ▾
These are replicated association markers in the curated JKDNA panel. Association is not diagnosis or necessarily clinical actionability; odds ratios are study-level effect estimates and do not provide absolute or personal risk.
Rare-disease and ClinVar P/LP cross-references
large searchable table ▾
The small curated clinical audit is followed by every SNV intersected with the local official GRCh37 ClinVar snapshot, restricted to pathogenic/likely pathogenic classifications with at least one review star. Array rare-site signals are candidates for QC and sequencing—not diagnoses.
Curated clinical marker audit
ClinVar intersection
Reference scope: CPIC guidelines · NHGRI-EBI GWAS Catalog · NCBI ClinVar downloads. ClinVar changes over time; this page represents the reference snapshot bundled with report v2.5.1.
